Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 12
Submit an article Journal homepage
192
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy

M.H. Kim Northwestern University, Feinberg School of Medicine, Chicago, IL, USACorrespondence[email protected]
,
J. Lin Sanofi-aventis, Bridgewater, NJ, USA
,
M. Hussein IMS Health, Inc., Falls Church, VA, USA
&
D. Battleman IMS Health, Inc., Falls Church, VA, USA
Pages 3037-3047 | Accepted 28 Sep 2009, Published online: 26 Oct 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Francisco Batel Marques, Ana Penedones, Diogo Mendes & Carlos Alves. (2016) A systematic review of observational studies evaluating costs of adverse drug reactions. ClinicoEconomics and Outcomes Research 8, pages 413-426.
Read now
Steven N Singh. (2012) Costs and clinical consequences of suboptimal atrial fibrillation management. ClinicoEconomics and Outcomes Research 4, pages 79-90.
Read now
Michael H Kim. (2012) Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation. Expert Review of Clinical Pharmacology 5:2, pages 163-171.
Read now
Anne B. Curtis. (2011) Update on the Clinical Management of Atrial Fibrillation: Guidelines and Beyond. Postgraduate Medicine 123:6, pages 7-20.
Read now

Articles from other publishers (6)

Janneke Hoogervorst-Schilp, Maaike Langelaan, Peter Spreeuwenberg, Martine C. de Bruijne & Cordula Wagner. (2015) Excess length of stay and economic consequences of adverse events in Dutch hospital patients. BMC Health Services Research 15:1.
Crossref
Alpesh N. Amin, Mehul Jhaveri & Jay Lin. (2013) Hospital Readmissions in US Atrial Fibrillation Patients. American Journal of Therapeutics 20:2, pages 143-150.
Crossref
Bernd Brüggenjürgen, Stefan Kohler, Nadja Ezzat, Thomas Reinhold & Stefan N. Willich. (2013) Cost Effectiveness of Antiarrhythmic Medications in Patients Suffering from Atrial Fibrillation. PharmacoEconomics 31:3, pages 195-213.
Crossref
Winghan Jacqueline Kwong, Siddhesh Kamat & Christy Fang. (2012) Resource Use and Cost Implications of Switching Among Warfarin Formulations in Atrial Fibrillation Patients. Annals of Pharmacotherapy 46:12, pages 1609-1616.
Crossref
Marc Cohen & Catalin Boiangiu. (2011) The Management of Patients with Atrial Fibrillation and Dronedarone’s Place in Therapy. Advances in Therapy 28:12, pages 1059-1077.
Crossref
Zhongsu Wang, Yong Zhang, Mei Gao, Jiangrong Wang, Qing Wang, Xiaojun Wang, Lequn Su & Yinglong Hou. (2012) Statin Therapy for the Prevention of Atrial Fibrillation: A Meta‐analysis of Randomized Controlled Trials. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:11, pages 1051-1062.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.